Kura Oncology

Aug 07, 2025

•

Jun 30, 2025

Kura Oncology Q2 2025 Earnings Report

Estimated Revenue:$65M

Estimated EPS:-$0.41

+33.5% YoY

Unlock previous datapoints

Unlock previous datapoints

Loading...

Analyze how earnings announcements historically affect stock price performance

Loading earnings performance data...

Loading earnings reaction data...

Full financial data and analysis

Market Cap

$745M

P/E Ratio

-4.09

Sector

N/A

Industry

N/A

52-Week High

$12.1

52-Week Low

$5.52